Brain, Vol. 119, No. 1, 249-256, 1996
© 1996 Oxford University Press
research-article |
Central activation of the trigeminovascular pathway in the cat is inhibited by dihydroergotamine
A c-Fos and electrophysiological study
1Institute of Neurology, The National Hospital for Neurology and Neurosurgery London, UK 2Department of Neurology Essen, Germany
Correspondence to:
Dr Peter J. Goadsby, Institute of Neurology, Queen Square, London WCIN 3BG, UK
Recent studies have delineated a clear role for the trigeminal innervation of pain-sensitive intracranial structures in the pathophysiology of migraine. The development of new compounds for the treatment of the acute attack of migraine has led to a greater understanding of serotonin (5-hydroxytryptamine; 5HT) receptor diversity. The ergot alkaloids have been used in the treatment of acute attacks of migraine for many years and parenteral administration of dihydroergotamine (DHE) can be a useful treatment strategy. In this study, the question of a possible central site of action of DHE is considered using both anatomical and physiological approaches. The c-Fos method has been used to map functional activation of central neurons in response to stimulation of the superior sagittal sinus (SSS) in the cat. This structure has been used as it refers pain to the ophthalmic division of the trigeminal nerve in humans, and in cats induces changes in neuropeptides and cranial blood flow similar to those seen in migraine. In addition, the temporal aspects of the effect of DHE have been studied by making extracellular recordings from cells in the most caudal aspect of the trigeminal nuclear complex. Stimulation of the SSS results in Fos expression in the superfical laminae of the trigeminal nucleus caudalis and in the dorsal horn of C1 and C2. This activation is blocked by a clinically relevant dose of DHE. Similarly, cells can be recorded in this region that respond to SSS stimulation. This linked cellular activity can be inhibited by the same intravenous dose of DHE. Together, these studies show that DHE can inhibit activity in central trigeminal neurons. Since the sinus and its nerve supply are directly stimulated, the peripheral nerve/vessel innervation is bypassed and this inhibition cannot have happened at any other site. These data imply that drugs acting at the central trigeminal neurons may have a role in the treatment of acute attacks of migraine.
headache; migraine; acute treatment; trigeminal nucleus; ergotamine
Received May 16, 1995. Revised July 19, 1995. Accepted August 23, 1995.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  G. G. Schoonman, J. van der Grond, C. Kortmann, R. J. van der Geest, G. M. Terwindt, and M. D. Ferrari Migraine headache is not associated with cerebral or meningeal vasodilatation--a 3T magnetic resonance angiography study Brain, August 1, 2008; 131(8): 2192 - 2200. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Levy, M. S. Matharu, K. Meeran, M. Powell, and P. J. Goadsby The clinical characteristics of headache in patients with pituitary tumours Brain, August 1, 2005; 128(8): 1921 - 1930. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Bartsch and P. J. Goadsby Increased responses in trigeminocervical nociceptive neurons to cervical input after stimulation of the dura mater Brain, August 1, 2003; 126(8): 1801 - 1813. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Goadsby, K. L. Hoskin, R. J. Storer, L. Edvinsson, and H. E. Connor Adenosine A1 receptor agonists inhibit trigeminovascular nociceptive transmission Brain, June 1, 2002; 125(6): 1392 - 1401. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Tfelt-Hansen, P. R. Saxena, C. Dahlof, J. Pascual, M. Lainez, P. Henry, H.-C. Diener, J. Schoenen, M. D. Ferrari, and P. J. Goadsby Ergotamine in the acute treatment of migraine: A review and European consensus Brain, January 1, 2000; 123(1): 9 - 18. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Burstein, H. Yamamura, A. Malick, and A. M. Strassman Chemical Stimulation of the Intracranial Dura Induces Enhanced Responses to Facial Stimulation in Brain Stem Trigeminal Neurons J Neurophysiol, February 1, 1998; 79(2): 964 - 982. [Abstract] [Full Text] [PDF]
|
|